Overview: Lynparza 150 mg (Olaparib)
Lynparza 150 mg, containing the active ingredient Olaparib, is a pioneering targeted therapy developed by AstraZeneca. It is classified as a poly (ADP-ribose) polymerase (PARP) inhibitor, scientifically formulated to interfere with the DNA repair mechanisms of cancer cells.
Mechanism and Clinical Utility
Lynparza works by inhibiting the PARP enzymes, which are critical for the repair of damaged DNA within cells. By blocking this repair pathway, Lynparza leads to the accumulation of DNA damage in cancer cells, ultimately causing them to stop dividing and die. This targeted approach is essential for patients managing specific types of ovarian, breast, pancreatic, and prostate cancers.
Key Therapeutic Benefits
- Targeted PARP Inhibition: Highly specific action that targets the DNA repair machinery of cancer cells to effectively control tumor growth.
- Advanced Oncology Support: Designed as a targeted therapy, offering a precise approach to managing various types of malignancies.
- Clinical Reliability: Developed by AstraZeneca, a global leader in oncology research, ensuring high standards of therapeutic efficacy.
- Precise Dosing: Provided as 150 mg film-coated tablets, allowing for flexible and accurate titration according to oncologist recommendations.
Product Details and Usage
Lynparza 150 mg is provided in a 56-tablet supply per unit. This presentation is designed to support the dosing schedules required for effective long-term oncology management, ensuring patients have reliable access to their prescribed treatment as shown in the product packaging .
Safety and Storage Guidelines
Administration: Must be taken strictly as prescribed by your oncologist. Adjustments to therapy or dosing must be performed only by authorized medical professionals.
Storage: Store the tablets in their original packaging in a cool, dry place. Keep out of reach of children and ensure the storage environment remains within standard temperature limits.
Healthcare Collaboration: Maintain consistent communication with your oncology care team and the specialists at El-Masry Pharmacy to ensure optimal treatment outcomes and to address any clinical concerns promptly.
Disclaimer: Lynparza is a specialized, prescription-only oncology medication. Ensure you hold a valid prescription and consult with your healthcare provider before beginning any treatment plan.
You can add a rating once you purchase the product through the My Orders page
